Astragaloside IV Attenuates Glutamate-Induced Neurotoxicity in PC12 Cells through Raf-MEK-ERK Pathway.
Astragaloside IV (AGS-IV) is a main active ingredient of Astragalus membranaceus Bunge, a medicinal herb prescribed as an immunostimulant, hepatoprotective, antiperspirant, a diuretic or a tonic as documented in Chinese Materia Medica. In the present study, we employed a high-throughput comparative...
Main Authors: | Rongcai Yue, Xia Li, Bingyang Chen, Jing Zhao, Weiwei He, Hu Yuan, Xing Yuan, Na Gao, Guozhen Wu, Huizi Jin, Lei Shan, Weidong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4427284?pdf=render |
Similar Items
-
Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
by: Hu Y, et al.
Published: (2022-05-01) -
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
by: Pui-Kei Wu, et al.
Published: (2020-07-01) -
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
by: Ufuk Degirmenci, et al.
Published: (2020-01-01) -
Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth
by: Rameswari Chilamakuri, et al.
Published: (2022-09-01) -
Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: we are not done yet.
by: Grant A. McArthur
Published: (2015-07-01)